Claes-Göran Östenson
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) (NCT01933529) | Claes-Göran Östenson | 2013-10-01 |
Track Claes-Göran Östenson automatically
Every clearance here is in the API, with alerts when new ones post.